HRP20241053T1 - Pirimidinski inhibitori jak, namijenjeni liječenju kožnih bolesti - Google Patents

Pirimidinski inhibitori jak, namijenjeni liječenju kožnih bolesti Download PDF

Info

Publication number
HRP20241053T1
HRP20241053T1 HRP20241053TT HRP20241053T HRP20241053T1 HR P20241053 T1 HRP20241053 T1 HR P20241053T1 HR P20241053T T HRP20241053T T HR P20241053TT HR P20241053 T HRP20241053 T HR P20241053T HR P20241053 T1 HRP20241053 T1 HR P20241053T1
Authority
HR
Croatia
Prior art keywords
pharmaceutically acceptable
acceptable salt
group
compound according
image
Prior art date
Application number
HRP20241053TT
Other languages
English (en)
Croatian (hr)
Inventor
Philip A. GERKEN
Jianhua Chao
Original Assignee
Theravance Biopharma R&D Ip, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Biopharma R&D Ip, Llc filed Critical Theravance Biopharma R&D Ip, Llc
Publication of HRP20241053T1 publication Critical patent/HRP20241053T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20241053TT 2019-04-24 2020-04-23 Pirimidinski inhibitori jak, namijenjeni liječenju kožnih bolesti HRP20241053T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962837827P 2019-04-24 2019-04-24
PCT/US2020/029466 WO2020219640A1 (en) 2019-04-24 2020-04-23 Pyrimidine jak inhibitors for the treatment of skin diseases
EP20727424.2A EP3959213B1 (en) 2019-04-24 2020-04-23 Pyrimidine jak inhibitors for the treatment of skin diseases

Publications (1)

Publication Number Publication Date
HRP20241053T1 true HRP20241053T1 (hr) 2024-11-08

Family

ID=70779856

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20241053TT HRP20241053T1 (hr) 2019-04-24 2020-04-23 Pirimidinski inhibitori jak, namijenjeni liječenju kožnih bolesti

Country Status (11)

Country Link
US (1) US11439641B2 (cg-RX-API-DMAC7.html)
EP (1) EP3959213B1 (cg-RX-API-DMAC7.html)
JP (1) JP7482152B2 (cg-RX-API-DMAC7.html)
AR (1) AR118767A1 (cg-RX-API-DMAC7.html)
CA (1) CA3135388A1 (cg-RX-API-DMAC7.html)
ES (1) ES2994097T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241053T1 (cg-RX-API-DMAC7.html)
HU (1) HUE067909T2 (cg-RX-API-DMAC7.html)
PL (1) PL3959213T3 (cg-RX-API-DMAC7.html)
TW (1) TW202106681A (cg-RX-API-DMAC7.html)
WO (1) WO2020219640A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA49956B1 (fr) 2017-10-27 2022-11-30 Theravance Biopharma R&D Ip Llc Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak
CN115925705B (zh) * 2018-11-30 2024-12-31 江苏豪森药业集团有限公司 杂芳类衍生物调节剂、其制备方法和应用
JP7470713B2 (ja) * 2019-04-24 2024-04-18 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー Jakキナーゼ阻害剤としてのエステルおよびカルボナートピリミジン化合物
WO2022083687A1 (zh) * 2020-10-21 2022-04-28 南京明德新药研发有限公司 硒杂环类化合物及其应用
WO2022094174A1 (en) * 2020-10-30 2022-05-05 Children's Hospital Medical Center Compositions and methods for the treatment of esophageal conditions
AU2022270072A1 (en) 2021-05-03 2023-11-02 Incyte Corporation Jak1 pathway inhibitors for the treatment of prurigo nodularis
JP2024516299A (ja) * 2021-05-03 2024-04-12 インサイト・コーポレイション 結節性痒疹の治療のためのルキソリチニブ
WO2023202706A1 (zh) * 2022-04-21 2023-10-26 南京明德新药研发有限公司 硒杂环类化合物的盐型和晶型及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
AU2001290912A1 (en) 2000-09-15 2002-03-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
BR0116493A (pt) 2000-12-21 2003-09-30 Vertex Pharma Compostos de pirazol úteis como inibidores de proteìna cinase
ATE508126T1 (de) 2005-11-16 2011-05-15 Vertex Pharma Als kinaseinhibitoren geeignete aminopyrimidine
TW200817391A (en) 2006-06-30 2008-04-16 Astrazeneca Ab Novel compounds
AU2007269540B2 (en) 2006-07-05 2013-06-27 Exelixis, Inc. Methods of using IGF1R and Abl kinase modulators
RU2014129740A (ru) 2011-12-22 2016-02-10 Ф.Хоффманн-Ля Рош Аг Производные 2,4-диаминопиримидина в качестве ингибиторов серин/треонин киназы
WO2015094803A1 (en) 2013-12-16 2015-06-25 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
NO2721710T3 (cg-RX-API-DMAC7.html) 2014-08-21 2018-03-31
ES2924698T3 (es) 2015-05-28 2022-10-10 Theravance Biopharma R&D Ip Llc Proceso e intermedios para la preparación de compuestos de naftiridina como inhibidores de quinasa JAK
WO2017189822A1 (en) 2016-04-28 2017-11-02 Theravance Biopharma R&D Ip, Llc Pyrimidine compounds as jak kinase inhibitors
CN106588885B (zh) * 2016-11-10 2019-03-19 浙江大学 2-取代芳环-嘧啶类衍生物及制备和应用
MA49956B1 (fr) 2017-10-27 2022-11-30 Theravance Biopharma R&D Ip Llc Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak
TWI740288B (zh) 2018-11-27 2021-09-21 大陸商江蘇豪森藥業集團有限公司 含氮雜芳類衍生物調節劑、其製備方法和應用
CN115925705B (zh) 2018-11-30 2024-12-31 江苏豪森药业集团有限公司 杂芳类衍生物调节剂、其制备方法和应用
JP7470713B2 (ja) * 2019-04-24 2024-04-18 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー Jakキナーゼ阻害剤としてのエステルおよびカルボナートピリミジン化合物
CN113372364B (zh) 2020-03-10 2024-05-31 明慧医药(上海)有限公司 一类jak激酶抑制剂及其制备和应用
CN113372351A (zh) 2020-03-10 2021-09-10 明慧医药(杭州)有限公司 一类jak激酶抑制剂及其制备和应用

Also Published As

Publication number Publication date
EP3959213C0 (en) 2024-06-05
US20200338073A1 (en) 2020-10-29
JP2022529371A (ja) 2022-06-21
CA3135388A1 (en) 2020-10-29
AR118767A1 (es) 2021-10-27
JP7482152B2 (ja) 2024-05-13
US11439641B2 (en) 2022-09-13
EP3959213A1 (en) 2022-03-02
TW202106681A (zh) 2021-02-16
EP3959213B1 (en) 2024-06-05
WO2020219640A1 (en) 2020-10-29
PL3959213T3 (pl) 2024-11-04
ES2994097T3 (en) 2025-01-17
HUE067909T2 (hu) 2024-11-28

Similar Documents

Publication Publication Date Title
HRP20240346T1 (hr) Esterski i karbonatni spojevi pirimidina kao inhibitori jak-kinaze
EP1971611B1 (en) Anti-viral compounds
JP4935357B2 (ja) 新規縮環イミダゾール誘導体
KR102319857B1 (ko) P2x7 조절제
AU2018353759B2 (en) Heterocyclic compound as a protein kinase inhibitor
AU2018388404B2 (en) Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
EP3489237B1 (en) 4-azaindole derivatives
JP6294953B2 (ja) P2x7調節物質
AU2013266110A1 (en) Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CN107922409A (zh) 作为parp抑制剂的杂芳基衍生物
EP3412669A1 (en) Tricyclic compound for bromodomain-containing protein inhibitor and preparation, pharmaceutical composition, and application thereof
SA06270020B1 (ar) مركبات جديدة للاستخدام في علاج حالات العدوى البكترية
EA026497B1 (ru) 6-алкинилпиридины в качестве миметиков smac
ME02672B (me) Fenil-3-aza-bicikl0[3.1.0]heks-3-il-metanoni i njihova primena kao medikament
KR20160056896A (ko) Pim 키나아제 억제제로서 유용한 푸로- 및 티에노-피리딘 카복사미드 화합물
KR20220027196A (ko) 이미다조[1,2-a]피리디닐 유도체 및 질병의 치료에서 이것들의 용도
CA3208951A1 (en) Pyrazolopyridine derivatives and uses thereof
AR118767A1 (es) Pirimidinas sustituidas como inhibidores de jak y su uso para el tratamiento de enfermedades inflamatorias o autoinmunes cutáneas
CA3299704A1 (en) A substituted-heterocyclic-c(o)o-(substituted pyridin-3-yl) compound and its use as a dual magl and faah inhibitor
KR20140125389A (ko) Mtor-저해제로서 피리미도옥사조신 유도체
JP6353899B2 (ja) ロイコトリエン生成の阻害剤
EP2903983A1 (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses
CN121399126A (zh) 具有gpr68调节活性的双环杂芳基酰胺
WO2024258769A1 (en) Antimalarial agents
RU2024135043A (ru) Пиримидиновое соединение, способ его получения и его фармацевтическое применение